|
|
|
| () | |
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: | |
Page 1 of 3
-
Oncology Conference Countdown: What Will Pharma and Biotech Companies Report?
on May 16, 2008 by Mike Huckman
-
Wall Street Breakfast: Must-Know News
on May 08, 2008 by SA Editor Eli Hoffmann
-
Former Merck CEO Prods Industry on Drug Pricing
on May 02, 2008 by Mike Huckman
-
Q1 Performance by Market Cap and Sector
on Apr 01, 2008 by Alan Brochstein
-
Under The Radar News - Thursday
on Mar 13, 2008 by SA Editor Eli Hoffmann
-
Pfizer Should Buy Amgen or Wyeth - Credit Suisse
on Mar 09, 2008 by Mike Huckman
-
Gold's Just Getting Started - Barron's Interview
on Feb 04, 2008 by SA Editor Eli Hoffmann
-
European Hedge: Pharmion and Celgene
on Feb 01, 2008 by Adam Rubenstein
-
2007 Biotech Performance Review
on Jan 21, 2008 by A. Reza Saadat
-
A Volatile January for Financials, Healthcare
on Jan 13, 2008 by Promod Radhakrishnan
-
Wal-Mart's Guidance Shows No Sign of Slow-Down, Good for Investors
on Jan 11, 2008 by Todd Sullivan
-
Pharma, Biotech Present Great Investment Opportunities in 2008
on Jan 09, 2008 by A. Reza Saadat
-
Celgene Puts Drug Scare Behind It
on Jan 07, 2008 by Brett Scott
-
7 Healthcare Stocks for a Sick Market
on Jan 06, 2008 by Alan Brochstein
-
Celgene Looks Like It's Bottoming - Citi
on Jan 03, 2008 by Notable Calls
-
SAC Capital Discloses 7% Stake in Pharmion
on Dec 26, 2007 by Lon Juricic
-
Thursday's Options Report: PIR, CELG, ERIC, Red Hat, MBI, ORCL, Nike
on Dec 20, 2007 by Andrew Wilkinson
-
A Super(Gen) Play on Cancer Biotech Consolidation
on Dec 16, 2007 by Mike Havrilla
-
Biotech Fund IBB May Ride the M&A Frenzy, but It's Still Wildly Volatile
on Dec 13, 2007 by Don Dion
-
Monday's Options Report: XLF, Novastar, CFC, CELG, Nike
on Dec 10, 2007 by Andrew Wilkinson
-
Stocks With the Most Analyst Love - or Lack Thereof
on Nov 29, 2007 by Bespoke Investment Group
-
Nasdaq 100's Top 25 PEG Plays
on Nov 28, 2007 by Bespoke Investment Group
-
Why Acquiring Pharmion Makes Sense for Celgene
on Nov 22, 2007 by Trader Thoughts
-
November 19th Merger Arbitrage Activity
on Nov 20, 2007 by Merger Arbitrage Investing
-
Celgene Buys Pharmion, Hopes to Be Global Cancer Drug Leader
on Nov 19, 2007 by SA Editor Yitzchak Fishel
-
Celgene Has Something Investors Want - Growth
on Oct 22, 2007 by Stock Geek
-
Nine Stem Cell Stocks to Add to Your Portfolio
on Oct 02, 2007 by Stockerblog
-
Cancer Stocks Finish a Tough Quarter
on Oct 01, 2007 by Alan Brochstein
-
Top Winners, Losers of the Current Bull Market
on Sep 28, 2007 by Bespoke Investment Group
-
Biotech Product Developments Should Make 2008 More Eventful Than 2007
on Sep 24, 2007 by A. Reza Saadat
-
Celgene Offers Investors The Growth They Want
on Sep 16, 2007 by Brett Scott
-
S&P 500 Stocks With the Highest Estimated Growth Rates
on Aug 08, 2007 by Bespoke Investment Group
-
Cash-Rich Companies: Watch Out for the Siren’s Song
on Jul 27, 2007 by Alan Brochstein
-
Jim Cramer's Mad Money Lightning Round Picks, 7/18/07
on Jul 19, 2007 by SA Editor Miriam Metzinger
-
Celgene, Genentech, Gilead: Is Biotech Weakness Creating A Buying Opportunity?
on Jul 05, 2007 by Brett Scott
-
Cancer Stocks Slide Again
on Jun 18, 2007 by Alan Brochstein
-
Insider Buys, Listed by Size
on Jun 18, 2007 by Todd Sullivan
-
Cancer Stocks Plunge Following ASCO Meeting
on Jun 11, 2007 by Alan Brochstein
-
Cancer Stocks Soar With Annual ASCO Meeting
on Jun 04, 2007 by Alan Brochstein
-
Celgene Still Seems To Be A Good Biotech Ride
on May 29, 2007 by Andrew Vaino
-
Cancer Stocks on the Go: Winners and Losers
on May 29, 2007 by Alan Brochstein
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »